Abpro Holdings Files 8-K with Corporate Updates
Ticker: ABPWW · Form: 8-K · Filed: Oct 22, 2025 · CIK: 1893219
Sentiment: neutral
Topics: corporate-action, filing, amendment
TL;DR
Abpro Holdings filed an 8-K on Oct 16, 2025, reporting corporate amendments and financial statements.
AI Summary
Abpro Holdings, Inc. filed an 8-K on October 22, 2025, reporting events as of October 16, 2025. The filing indicates amendments to its articles of incorporation or bylaws and includes financial statements and exhibits. The company, formerly Atlantic Coastal Acquisition Corp. II, is incorporated in Delaware and has its principal executive offices in New York.
Why It Matters
This 8-K filing signals potential changes in Abpro Holdings' corporate structure or financial reporting, which could impact investors' understanding of the company's governance and financial health.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant negative news or events.
Key Players & Entities
- Abpro Holdings, Inc. (company) — Registrant
- Atlantic Coastal Acquisition Corp. II (company) — Former company name
- October 16, 2025 (date) — Earliest event date
- October 22, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- New York (location) — Business address city
FAQ
What specific amendments were made to Abpro Holdings' articles of incorporation or bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the excerpt. Further review of the attached exhibits would be necessary.
What is the significance of the date October 16, 2025, for this filing?
October 16, 2025, is the date of the earliest event reported in this 8-K filing.
When was Abpro Holdings, Inc. previously known as?
Abpro Holdings, Inc. was formerly known as Atlantic Coastal Acquisition Corp. II.
In which state is Abpro Holdings, Inc. incorporated?
Abpro Holdings, Inc. is incorporated in Delaware.
What type of business is Abpro Holdings, Inc. primarily involved in?
Abpro Holdings, Inc. is primarily involved in Biological Products (No Diagnostic Substances), with a Standard Industrial Classification code of 2836.
Filing Stats: 832 words · 3 min read · ~3 pages · Grade level 11.6 · Accepted 2025-10-22 17:00:27
Key Financial Figures
- $0.0001 — red Shares of Common Stock, par value $0.0001 per share ABP The Nasdaq Stock Mark
- $11.50 — of Common Stock at an exercise price of $11.50 ABPWW The Nasdaq Stock Market LLC
Filing Documents
- ea0261855-8k_abpro.htm (8-K) — 31KB
- ea026185501ex3-1_abpro.htm (EX-3.1) — 11KB
- 0001213900-25-101285.txt ( ) — 254KB
- abpww-20251016.xsd (EX-101.SCH) — 4KB
- abpww-20251016_def.xml (EX-101.DEF) — 26KB
- abpww-20251016_lab.xml (EX-101.LAB) — 36KB
- abpww-20251016_pre.xml (EX-101.PRE) — 25KB
- ea0261855-8k_abpro_htm.xml (XML) — 6KB
03 Amendments to Articles of Incorporation
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On October 16, 2025, Abpro Holdings, Inc. (the "Company") filed with the Delaware Secretary of State a Certificate of Amendment to the Certificate of Incorporation of the Company (the "Certificate of Amendment"), which will become effective at 5:01 p.m. on October 31, 2025 (the "Effective Time"), to effect a one-for-thirty (1:30) reverse stock split (the "Reverse Stock Split"), of the shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"). The Reverse Stock Split was approved by the Company's stockholders at the 2025 annual meeting of the stockholders on October 10, 2025. As a result of the Reverse Stock Split, every 30 shares of issued and outstanding Common Stock will be automatically combined into one (1) issued and outstanding share of Common Stock, without any change in the par value per share. No fractional shares will be issued as a result of the Reverse Stock Split. Instead, stockholders who otherwise would have been entitled to receive fractional shares because they held a number of shares not evenly divisible by the Reverse Stock Split ratio will be entitled to receive an additional fraction of a share of Common Stock to round up to the next whole share. Following the Reverse Stock Split, the number of shares of Common Stock outstanding will be proportionally reduced from 81,150,000 shares to approximately 2,705,000 shares. The shares of Common Stock underlying the Company's outstanding stock options and warrants will be similarly adjusted along with corresponding adjustments to their exercise prices. The Company's transfer agent, Continental Stock Transfer & Trust Company, is the exchange agent for the Reverse Stock Split and will correspond with stockholders of record regarding the Reverse Stock Split. Stockholders owning shares via a broker or other nominee will have their positions automatically adjusted to reflect the Reverse Stock S
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 3.1 Certificate of Amendment to Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on October 16, 2025. 104 Cover Page Interactive Data File (embedded within the inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ABPRO HOLDINGS, INC. By: /s/ Miles Suk Name: Miles Suk Title: Chief Executive Officer Dated: October 22, 2025 2